United States Biotechnology & Medical Research

Timber Pharmaceuticals Inc (TMBR)

Track

Ticker: TMBR Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Koconis John CEO & President Executive Director
Transaction date
Purchase
Price
321.45
Quantity 89,892 +2.8%
Value US$4,480,287
Sitar Edward J Non-Executive Director
Transaction date
Purchase
Price
366.81
Quantity 57,566 -3.7%
Value US$1,343,161
Mendelsohn Alan Chief Medical Officer Officer
Transaction date
Purchase
Price
488.35
Quantity 4,559 +19.2%
Value US$3,526,897
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 50,000 -1.1%
Value US$45,395
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 50,000 -1.1%
Value US$47,700
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.00
Quantity 75,000 -1.6%
Value US$75,075
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.26
Quantity 185,229 -3.7%
Value US$233,926
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.27
Quantity 96,481 -1.9%
Value US$122,907
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.29
Quantity 305,540 -5.7%
Value US$393,383
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.26
Quantity 9,879 -0.2%
Value US$12,448
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.26
Quantity 8,670 -0.2%
Value US$10,952
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.27
Quantity 47,736 -0.9%
Value US$60,620
Mendelsohn Alan Chief Medical Officer Officer
Transaction date
Purchase
Price
2.17
Quantity 1,988 +inf%
Value US$4,314
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.03
Quantity 100,694 -1.8%
Value US$103,695
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.03
Quantity 87,060 -1.5%
Value US$89,550
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.03
Quantity 455 -0.0%
Value US$469
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.03
Quantity 7,483 -0.1%
Value US$7,710
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
1.04
Quantity 32,943 -0.6%
Value US$34,379
0.5
TardiMed Sciences LLC Large shareholder
Transaction date
Sale
Price
0.01
Quantity 55,008 -2.4%
Value US$550
3.7
Vivo Capital VIII, LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 327,870 -50.8%
Value US$334,427
Krammer Anja B Non-Executive Director
Transaction date
Sale
Price
0.11
Quantity 115,874 -5.8%
Value US$12,746
Morlock Stephen Non-Executive Director
Transaction date
Sale
Price
0.18
Quantity 251,071 -100.0%
Value US$45,193
Morlock Stephen Non-Executive Director
Transaction date
Sale
Price
0.18
Quantity 220,766 -100.0%
Value US$39,738
Morlock Stephen Non-Executive Director
Transaction date
Sale
Price
0.18
Quantity 214,091 -49.2%
Value US$38,536
Morlock Stephen Non-Executive Director
Transaction date
Sale
Price
0.19
Quantity 439,099 -50.2%
Value US$83,429
Krammer Anja B Non-Executive Director
Transaction date
Sale
Price
0.19
Quantity 297,500 -12.9%
Value US$56,525
Krammer Anja B Non-Executive Director
Transaction date
Sale
Price
0.19
Quantity 100,000 -4.2%
Value US$19,000
Krammer Anja B Non-Executive Director
Transaction date
Sale
Price
0.19
Quantity 102,500 -4.1%
Value US$19,475
Tierney David S CEO Executive Director
Transaction date
Purchase
Price
0.20
Quantity 100,000 +1.4%
Value US$20,250
Vivo Capital VIII, LLC Large shareholder
Transaction date
Sale
Price
0.36
Quantity 2,000,000 -11.0%
Value US$720,000
Morlock Stephen
Transaction date
Purchase
Price
0.15
Quantity 330,000 +60.7%
Value US$49,500
Vivo Capital VIII, LLC Large shareholder
Transaction date
Sale
Price
0.20
Quantity 296,394 -2.1%
Value US$59,279
FRANKLIN RESOURCES INC Large shareholder
Transaction date
Purchase
Price
0.34
Quantity 250,000 +2.6%
Value US$84,300
Vivo Capital Fund VIII, L.P. Large shareholder
Transaction date
Purchase
Price
0.78
Quantity 1,282,052 +10.0%
Value US$1,000,001
FRANKLIN RESOURCES INC Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 4,375,000
Value US$0
FRANKLIN RESOURCES INC Large shareholder
Transaction date
Purchase
Price
0.65
Quantity 484,615 +10.4%
Value US$315,000
FRANKLIN RESOURCES INC Large shareholder
Transaction date
Purchase
Price
1.20
Quantity 540,000 +13.2%
Value US$648,000
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.53
Quantity 5,500 +2.2%
Value US$8,415
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.52
Quantity 6,500 +2.7%
Value US$9,880
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.63
Quantity 3,000 +1.3%
Value US$4,890
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.43
Quantity 3,000 +1.3%
Value US$4,290
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.47
Quantity 5,000 +2.2%
Value US$7,350
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 3,000 +1.3%
Value US$3,690
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.25
Quantity 2,000 +0.9%
Value US$2,500
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.19
Quantity 2,000 +0.9%
Value US$2,380
Morlock Stephen Non-Executive Director
Transaction date
Purchase
Price
1.26
Quantity 1,000 +0.5%
Value US$1,260
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-16 2021-12-15 B Purchase
Koconis John

CEO & President

Executive Director
89,892 +2.8%
321.45
US$4,480,287 		89,892 +2.8% 321.45 US$4,480,287
2021-11-24 2021-11-23 B Purchase
Sitar Edward J
Non-Executive Director
57,566 -3.7%
366.81
US$1,343,161 		57,566 -3.7% 366.81 US$1,343,161
2021-11-24 2021-11-23 B Purchase
Mendelsohn Alan

Chief Medical Officer

Officer
4,559 +19.2%
488.35
US$3,526,897 		4,559 +19.2% 488.35 US$3,526,897
2021-08-20 2021-08-20 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
50,000 -1.1%
0.91
US$45,395 		50,000 -1.1% 0.91 US$45,395
2021-08-20 2021-08-19 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
50,000 -1.1%
0.95
US$47,700 		50,000 -1.1% 0.95 US$47,700
2021-08-20 2021-08-18 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
75,000 -1.6%
1.00
US$75,075 		75,000 -1.6% 1.00 US$75,075
2021-06-10 2021-06-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
185,229 -3.7%
1.26
US$233,926 		185,229 -3.7% 1.26 US$233,926
2021-06-10 2021-06-09 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
96,481 -1.9%
1.27
US$122,907 		96,481 -1.9% 1.27 US$122,907
2021-06-10 2021-06-08 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
305,540 -5.7%
1.29
US$393,383 		305,540 -5.7% 1.29 US$393,383
2021-06-02 2021-06-02 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
9,879 -0.2%
1.26
US$12,448 		9,879 -0.2% 1.26 US$12,448
2021-06-02 2021-06-01 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
8,670 -0.2%
1.26
US$10,952 		8,670 -0.2% 1.26 US$10,952
2021-06-02 2021-05-28 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
47,736 -0.9%
1.27
US$60,620 		47,736 -0.9% 1.27 US$60,620
2021-05-13 2021-03-03 B Purchase
Mendelsohn Alan

Chief Medical Officer

Officer
1,988 +inf%
2.17
US$4,314 		1,988 +inf% 2.17 US$4,314
2020-09-16 2020-09-16 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
100,694 -1.8%
1.03
US$103,695 		100,694 -1.8% 1.03 US$103,695
2020-09-16 2020-09-15 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
87,060 -1.5%
1.03
US$89,550 		87,060 -1.5% 1.03 US$89,550
2020-09-16 2020-09-14 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
455 -0.0%
1.03
US$469 		455 -0.0% 1.03 US$469
2020-09-14 2020-09-11 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
7,483 -0.1%
1.03
US$7,710 		7,483 -0.1% 1.03 US$7,710
2020-09-14 2020-09-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
32,943 -0.6%
1.04
US$34,379 		32,943 -0.6% 1.04 US$34,379
2020-02-12 2020-02-10 S Sale
Timber Pharmaceuticals LLC
Large shareholder
55,008 -2.4%
0.01
US$550 		55,008 -2.4% 0.01 US$550
2020-02-12 2020-02-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
55,008 -2.4%
0.01
US$550 		55,008 -2.4% 0.01 US$550
2019-06-27 2019-06-25 S Sale
3.7
Vivo Capital VIII, LLC
Large shareholder
327,870 -50.8%
1.02
US$334,427 		327,870 -50.8% 1.02 US$334,427
2019-01-25 2019-01-23 S Sale
Krammer Anja B
Non-Executive Director
115,874 -5.8%
0.11
US$12,746 		115,874 -5.8% 0.11 US$12,746
2018-10-22 2018-10-22 S Sale Morlock Stephen Non-Executive Director
251,071 -100.0%
0.18
US$45,193 		251,071 -100.0% 0.18 US$45,193
2018-10-22 2018-10-22 S Sale Morlock Stephen Non-Executive Director
220,766 -100.0%
0.18
US$39,738 		220,766 -100.0% 0.18 US$39,738
2018-10-22 2018-10-19 S Sale Morlock Stephen Non-Executive Director
214,091 -49.2%
0.18
US$38,536 		214,091 -49.2% 0.18 US$38,536
2018-10-22 2018-10-18 S Sale Morlock Stephen Non-Executive Director
439,099 -50.2%
0.19
US$83,429 		439,099 -50.2% 0.19 US$83,429
2018-10-12 2018-10-12 S Sale Krammer Anja B Non-Executive Director
297,500 -12.9%
0.19
US$56,525 		297,500 -12.9% 0.19 US$56,525
2018-10-12 2018-10-11 S Sale Krammer Anja B Non-Executive Director
100,000 -4.2%
0.19
US$19,000 		100,000 -4.2% 0.19 US$19,000
2018-10-12 2018-10-10 S Sale Krammer Anja B Non-Executive Director
102,500 -4.1%
0.19
US$19,475 		102,500 -4.1% 0.19 US$19,475
2018-09-20 2018-09-19 B Purchase Tierney David S

CEO

Executive Director
100,000 +1.4%
0.20
US$20,250 		100,000 +1.4% 0.20 US$20,250
2018-03-09 2018-03-07 S Sale Vivo Capital VIII, LLC Large shareholder
2,000,000 -11.0%
0.36
US$720,000 		2,000,000 -11.0% 0.36 US$720,000
2017-11-27 2017-11-24 B Purchase Morlock Stephen
330,000 +60.7%
0.15
US$49,500 		330,000 +60.7% 0.15 US$49,500
2017-11-13 2017-11-09 S Sale Vivo Capital VIII, LLC Large shareholder
296,394 -2.1%
0.20
US$59,279 		296,394 -2.1% 0.20 US$59,279
2017-08-03 2017-08-01 B Purchase FRANKLIN RESOURCES INC Large shareholder
250,000 +2.6%
0.34
US$84,300 		250,000 +2.6% 0.34 US$84,300
2017-05-01 2017-04-28 B Purchase Vivo Capital Fund VIII, L.P. Large shareholder
1,282,052 +10.0%
0.78
US$1,000,001 		1,282,052 +10.0% 0.78 US$1,000,001
2016-11-30 2016-11-22 B Purchase FRANKLIN RESOURCES INC Large shareholder
4,375,000
0.00
US$0 		4,375,000 0.00 US$0
2016-08-16 2016-08-15 B Purchase FRANKLIN RESOURCES INC Large shareholder
484,615 +10.4%
0.65
US$315,000 		484,615 +10.4% 0.65 US$315,000
2016-03-31 2016-03-29 B Purchase FRANKLIN RESOURCES INC Large shareholder
540,000 +13.2%
1.20
US$648,000 		540,000 +13.2% 1.20 US$648,000
2016-01-15 2016-01-14 B Purchase Morlock Stephen Non-Executive Director
5,500 +2.2%
1.53
US$8,415 		5,500 +2.2% 1.53 US$8,415
2016-01-15 2016-01-13 B Purchase Morlock Stephen Non-Executive Director
6,500 +2.7%
1.52
US$9,880 		6,500 +2.7% 1.52 US$9,880
2016-01-12 2016-01-12 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.63
US$4,890 		3,000 +1.3% 1.63 US$4,890
2016-01-12 2016-01-11 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.43
US$4,290 		3,000 +1.3% 1.43 US$4,290
2016-01-11 2016-01-07 B Purchase Morlock Stephen Non-Executive Director
5,000 +2.2%
1.47
US$7,350 		5,000 +2.2% 1.47 US$7,350
2015-10-15 2015-10-15 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.23
US$3,690 		3,000 +1.3% 1.23 US$3,690
2015-10-15 2015-10-14 B Purchase Morlock Stephen Non-Executive Director
2,000 +0.9%
1.25
US$2,500 		2,000 +0.9% 1.25 US$2,500
2015-10-13 2015-10-09 B Purchase Morlock Stephen Non-Executive Director
2,000 +0.9%
1.19
US$2,380 		2,000 +0.9% 1.19 US$2,380
2015-10-13 2015-10-09 B Purchase Morlock Stephen Non-Executive Director
1,000 +0.5%
1.26
US$1,260 		1,000 +0.5% 1.26 US$1,260
Explore more

More insider trading research around Timber Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America